Diffuse Bio
YC W23San Francisco, US · Founded 2022 · 10 employees · Hiring · 3 known investors
Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryDeep LearningGenerative AIMachine LearningUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W23)
Diffuse Bio was founded in 2022 by Namrata Anand.
NA
Namrata AnandinFounderNamrata Anand is a bioengineer and computer scientist who has worked on machine learning applications in biology, including computational protein design using AI techniques and diffusion models for protein structure prediction.
Investors · 3
.jpeg){kind=logo}
Competitors · 4
by search overlapBodyBio5 shared keywordsBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
Generate Biomedicines5 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Dren Bio5 shared keywordsDren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
Transition Bio4 shared keywordsTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Companies competing with Diffuse Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Diffuse Bio do?
- Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
- Who founded Diffuse Bio?
- Diffuse Bio was founded by Namrata Anand in 2022.
- Who are Diffuse Bio's investors?
- Diffuse Bio's investors include GreatPoint Ventures, Humba Ventures, Y Combinator.
- Where is Diffuse Bio headquartered?
- Diffuse Bio is headquartered in San Francisco, US.